A Hearn

1.0k total citations
24 papers, 643 citations indexed

About

A Hearn is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, A Hearn has authored 24 papers receiving a total of 643 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Physiology, 11 papers in Pulmonary and Respiratory Medicine and 8 papers in Surgery. Recurrent topics in A Hearn's work include Asthma and respiratory diseases (18 papers), Eosinophilic Esophagitis (8 papers) and Respiratory and Cough-Related Research (7 papers). A Hearn is often cited by papers focused on Asthma and respiratory diseases (18 papers), Eosinophilic Esophagitis (8 papers) and Respiratory and Cough-Related Research (7 papers). A Hearn collaborates with scholars based in United Kingdom, Ireland and Canada. A Hearn's co-authors include David J. Jackson, Joanne Kavanagh, Brian D. Kent, Eli Silber, Jaideep Dhariwal, Linda K. Green, Cris Roxas, Louise Thomson, G d’Ancona and Mariana Fernandes and has published in prestigious journals such as CHEST Journal, Psychological Medicine and European Respiratory Journal.

In The Last Decade

A Hearn

22 papers receiving 636 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A Hearn United Kingdom	13	409	321	116	115	99	24	643
Achilles Athanassiou United States	13	101 0.2×	33 0.1×	246 2.1×	79 0.7×	67 0.7×	16	720
Omar F. Husein United States	10	187 0.5×	172 0.5×	12 0.1×	10 0.1×	107 1.1×	12	412
Nikolaus Ballenberger Germany	12	156 0.4×	45 0.1×	105 0.9×	43 0.4×	39 0.4×	33	435
Sigurður Júlíusson Iceland	24	1.1k 2.6×	327 1.0×	147 1.3×	503 4.4×	184 1.9×	47	1.4k
Hoa Pham Vietnam	18	45 0.1×	166 0.5×	63 0.5×	31 0.3×	53 0.5×	43	765
Francesco Ronchetti Italy	13	153 0.4×	71 0.2×	25 0.2×	50 0.4×	31 0.3×	28	402
Alexandra Rodriguez Belgium	17	131 0.3×	271 0.8×	81 0.7×	20 0.2×	197 2.0×	48	748
R. Carignola Italy	11	46 0.1×	17 0.1×	106 0.9×	8 0.1×	33 0.3×	22	406
William G. Karow United States	9	51 0.1×	96 0.3×	158 1.4×	7 0.1×	74 0.7×	14	794
Yi‐Han Hsiao Taiwan	12	179 0.4×	228 0.7×	42 0.4×	20 0.2×	29 0.3×	37	461

Countries citing papers authored by A Hearn

Since Specialization

Citations

This map shows the geographic impact of A Hearn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Hearn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Hearn more than expected).

Fields of papers citing papers by A Hearn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Hearn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Hearn. The network helps show where A Hearn may publish in the future.

Co-authorship network of co-authors of A Hearn

This figure shows the co-authorship network connecting the top 25 collaborators of A Hearn. A scholar is included among the top collaborators of A Hearn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Hearn. A Hearn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nanzer, Alexandra M., Linda K. Green, Louise Thomson, et al.. (2024). Long-Term Effectiveness of Benralizumab in Eosinophilic Granulomatosis With Polyangiitis. The Journal of Allergy and Clinical Immunology In Practice. 12(3). 724–732. 13 indexed citations

Khan, Mohammad Saud, et al.. (2024). DISSEMINATED CRYPTOCOCCUS NEOFORMANS IN A PATIENT WITH RHEUMATOID ARTHRITIS ON METHOTREXATE MONOTHERAPY. CHEST Journal. 166(4). A1308–A1309.

Rupani, Hitasha, Rekha Chaudhuri, Steven J. Smith, et al.. (2024). Preserved antibody responses to COVID-19 vaccination and lower odds of developing COVID-19 in adults with severe asthma. The Journal of Allergy and Clinical Immunology In Practice. 12(9). 2510–2513.e2.

Hearn, A, Mariana Fernandes, Linda K. Green, et al.. (2024). Long-Term Effectiveness of Anti-IL-4R Therapy Following Suboptimal Response to Anti-IL-5/5R Therapy in Severe Eosinophilic Asthma. The Journal of Allergy and Clinical Immunology In Practice. 12(7). 1794–1800. 18 indexed citations

Hearn, A, et al.. (2022). The prevalence of mucus plugging in severe eosinophilic asthma and its relationship to clinical efficacy of anti–IL-5R treatment. The Journal of Allergy and Clinical Immunology In Practice. 10(4). 1102–1103.e1. 8 indexed citations

d’Ancona, G, Joanne Kavanagh, Jaideep Dhariwal, et al.. (2021). Adherence to inhaled corticosteroids and clinical outcomes following a year of benralizumab therapy for severe eosinophilic asthma. Allergy. 76(7). 2238–2241. 18 indexed citations

Hearn, A, Joanne Kavanagh, G d’Ancona, et al.. (2021). Real world effectiveness of anti-IL-5/5R therapies is independent of co-eligibility for anti-IgE therapy. European Respiratory Journal. 57(6). 2100166–2100166. 3 indexed citations

Kavanagh, Joanne, A Hearn, & David J. Jackson. (2021). A pragmatic guide to choosing biologic therapies in severe asthma. Breathe. 17(4). 210144–210144. 32 indexed citations

Dhariwal, Jaideep, A Hearn, Joanne Kavanagh, et al.. (2021). Real-World Effectiveness of Anti–IL-5/5R Therapy in Severe Atopic Eosinophilic Asthma with Fungal Sensitization. The Journal of Allergy and Clinical Immunology In Practice. 9(6). 2315–2320.e1. 30 indexed citations

10.

Hearn, A, Joanne Kavanagh, G d’Ancona, et al.. (2021). The relationship between Feno and effectiveness of mepolizumab and benralizumab in severe eosinophilic asthma. The Journal of Allergy and Clinical Immunology In Practice. 9(5). 2093–2096.e1. 49 indexed citations

11.

Bains, Sarina, et al.. (2021). P105 Does asthma control change when patients transition to home administration of mepolizumab?. A144.2–A145. 1 indexed citations

12.

Nanzer, Alexandra M., Jaideep Dhariwal, Joanne Kavanagh, et al.. (2020). Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitis. ERJ Open Research. 6(4). 451–2020. 31 indexed citations

13.

Kavanagh, Joanne, A Hearn, G d’Ancona, et al.. (2020). Benralizumab after sub‐optimal response to mepolizumab in severe eosinophilic asthma. Allergy. 76(6). 1890–1893. 35 indexed citations

14.

Kavanagh, Joanne, A Hearn, Jaideep Dhariwal, et al.. (2020). Real-World Effectiveness of Benralizumab in Severe Eosinophilic Asthma. CHEST Journal. 159(2). 496–506. 187 indexed citations

15.

Hearn, A, Brian D. Kent, & David J. Jackson. (2020). Biologic treatment options for severe asthma. Current Opinion in Immunology. 66. 151–160. 20 indexed citations

16.

Hearn, A, G d’Ancona, Cris Roxas, et al.. (2020). The Response to Benralizumab at 1 Year After A Sub-Optimal Response to Mepolizumab in Severe Eosinophilic Asthma. A4265–A4265. 1 indexed citations

17.

Kavanagh, Joanne, Cris Roxas, Linda K. Green, et al.. (2020). Super-responder analysis and real-world one year effectiveness of benralizumab in severe eosinophilic asthma. 2261–2261. 3 indexed citations

18.

Heckmann, Jeannine M., Komala Pillay, A Hearn, & Chris Kenyon. (2010). Polymyositis in African HIV-infected subjects. Neuromuscular Disorders. 20(11). 735–739. 15 indexed citations

19.

Hearn, A & Eli Silber. (2010). Osteoporosis in multiple sclerosis. Multiple Sclerosis Journal. 16(9). 1031–1043. 70 indexed citations

20.

Watson, Stuart, et al.. (2002). Hypothalamic–pituitary–adrenal axis function in patients with chronic depression. Psychological Medicine. 32(6). 1021–1028. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact